Neurology News and Research

Latest Neurology News and Research

Combination of daclizumab and interferon beta significantly reduces MS lesion formation

Biogen Idec and Facet Biotech Corporation today announced the publication of Phase 2 data showing that the addition of daclizumab to interferon beta (IFNβ) led to a significant reduction in the number of new or enlarged multiple sclerosis (MS) lesions when compared to IFNβ alone in patients with active relapsing forms of MS.

17 Feb 2010

Even with new medical schools opening, shortages mar workforce

Nearly two dozen medical schools have recently opened or may open across America, "the most at any time since the 1960s and '70s," The New York Times reports. These new institutions "are seeking to address an imbalance in American medicine that has been growing for a quarter century. Many bright students were fleeing to offshore medical schools, or giving up hope entirely, when they could not get into domestic schools. Meanwhile, American hospitals were using foreign-trained and foreign-born physicians to fill medical residencies. During the 1980s and '90s only one new medical school was established."

17 Feb 2010

Simple, inexpensive test to help determine concussion in athletes

A simple test of reaction time may help determine whether athletes have sustained a concussion (also known as mild traumatic brain injury) and when they are ready to play again, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

16 Feb 2010

Researchers find new risk factor for early-onset dementia

Examining brain tissue from over 500 individuals in 11 countries, researchers from the University of Pennsylvania School of Medicine and the Children's Hospital of Philadelphia, and colleagues found a new risk factor for the second-most-common cause of early-onset dementia after Alzheimer's disease.

16 Feb 2010

Clive Svendsen to receive American Academy of Neurology Sheila Essey Award for his research on ALS

Clive Svendsen, Ph.D., director of the Cedars-Sinai Regenerative Medicine Institute, is receiving the American Academy of Neurology Sheila Essey Award for his research on ALS (amyothrophic lateral sclerosis).

16 Feb 2010

Research findings highlight the vital need for better secondary stroke prevention

New research finds that one out of 12 people who have a stroke will likely soon have another stroke, and one out of four will likely die within one year. Researchers say the findings highlight the vital need for better secondary stroke prevention. The study is published in the February 16, 2010, issue of Neurology-, the medical journal of the American Academy of Neurology.

16 Feb 2010

TV medical dramas show inaccurate seizure management

Watching TV medical shows might not be the best way to learn what to do when someone has a seizure. Researchers screened the most popular medical dramas and found that doctors and nurses on the shows responded inappropriately to seizures almost half the time, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

15 Feb 2010

Study shows poor sleep quality increases risk of motor vehicle accidents in adolescents

A study in the Feb. 15 issue of the Journal of Clinical Sleep Medicine shows that sleepiness at the wheel and poor sleep quality significantly increase the risk of motor vehicle accidents in adolescents.

15 Feb 2010

HSS creates Quality Research Center for applying research methodologies to health-care quality issues

Patients with orthopedic and autoimmune conditions expect Hospital for Special Surgery --because of its leadership role--to deliver the highest quality care. To further accomplish this mission, HSS is announcing the creation of a Quality Research Center with an innovative structure for applying research methodologies to health-care quality issues.

15 Feb 2010

Chocolates may reduce risk of death after stroke

Giving chocolates to your Valentine on February 14th may help lower their risk of stroke based on a preliminary study from researchers at St. Michael's Hospital. The study, which is being presented at the American Academy of Neurology in April, also found that eating chocolate may lower the risk of death after suffering a stroke.

15 Feb 2010

First FDA-approved umbilical cord blood stem cells infusion trial in children with cerebral palsy

Medical College of Georgia researchers are conducting the first FDA-approved clinical trial to determine whether an infusion of stem cells from umbilical cord blood can improve the quality of life for children with cerebral palsy.

12 Feb 2010

MacSpeech Scribe Medical add-on component released

MacSpeech, Inc. today announced MacSpeech Scribe Medical, an add-on component that incorporates the world's most advanced personal transcription for the Macintosh with MacSpeech Dictate Medical, the medical professional's speech recognition solution for the Macintosh.

12 Feb 2010

Eating chocolates may lower stroke risk, but more research is needed

Eating chocolate may lower your risk of having a stroke, according to an analysis of available research that will be released today and presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010. Another study found that eating chocolate may lower the risk of death after suffering a stroke.

11 Feb 2010

PAREXEL International, Proteome Sciences form biomarker alliance

PAREXEL International Corporation, a leading global biopharmaceutical services provider, and Proteome Sciences plc, a leading provider of protein biomarker discovery, validation, and assay development services, today announced the formation of an alliance focused on enhancing PAREXEL's biomarker capabilities for early phase clinical development. PAREXEL is using Proteome Sciences' PS Biomarker Services™ protein and peptide biomarker capabilities to support biopharmaceutical companies in making earlier assessments of new compounds in development.

From Parexel 11 Feb 2010

Headache is a common and persistent symptom in people exposed to dust at World Trade Center

Workers and residents exposed to dust and fumes caused by the collapse of the World Trade Center on September 11, 2001 frequently reported headache years later, according to research released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

11 Feb 2010

Neurology researchers explore link between MS and chronic cerebrospinal venous insufficiency

More than 55 percent of multiple sclerosis patients participating in the initial phase of the first randomized clinical study to determine if persons with MS exhibit narrowing of the extracranial veins, causing restriction of normal outflow of blood from the brain, were found to have the abnormality.

11 Feb 2010

Migraine sufferers face increase risk of heart attack, says study

People with migraine may be at an increased risk of heart attack and other risk factors for heart disease, according to a study published in the February 10, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology.

11 Feb 2010

NeuroMetrix announces 2009 fourth quarter financial results

NeuroMetrix, Inc., a health care company transforming patient care through neurotechnology, today announced its financial results for the three months and year ended December 31, 2009.

10 Feb 2010

Concomitant use of dexlansoprazole and other PPIs with Plavix: TGRD U.S. initiates trial

Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) announced today that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix (clopidogrel bisulfate) in healthy subjects. Takeda has been evaluating all published data and communications from the U.S. Food and Drug Administration (FDA) regarding the potential risks associated with concomitant use of clopidogrel and PPIs.

10 Feb 2010

Huntington's disease: Latrepirdine appears well-tolerated and beneficial

A medication previously studied in patients with Alzheimer's disease (latrepirdine) appears well tolerated and may improve thinking, learning and memory skills among individuals with Huntington's disease, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.

10 Feb 2010

Neurology News and Research

Latest Neurology News and Research

Combination of daclizumab and interferon beta significantly reduces MS lesion formation

Even with new medical schools opening, shortages mar workforce

Simple, inexpensive test to help determine concussion in athletes

Researchers find new risk factor for early-onset dementia

Clive Svendsen to receive American Academy of Neurology Sheila Essey Award for his research on ALS

Research findings highlight the vital need for better secondary stroke prevention

TV medical dramas show inaccurate seizure management

Study shows poor sleep quality increases risk of motor vehicle accidents in adolescents

HSS creates Quality Research Center for applying research methodologies to health-care quality issues

Chocolates may reduce risk of death after stroke

First FDA-approved umbilical cord blood stem cells infusion trial in children with cerebral palsy

MacSpeech Scribe Medical add-on component released

Eating chocolates may lower stroke risk, but more research is needed

PAREXEL International, Proteome Sciences form biomarker alliance

Headache is a common and persistent symptom in people exposed to dust at World Trade Center

Neurology researchers explore link between MS and chronic cerebrospinal venous insufficiency

Migraine sufferers face increase risk of heart attack, says study

NeuroMetrix announces 2009 fourth quarter financial results

Concomitant use of dexlansoprazole and other PPIs with Plavix: TGRD U.S. initiates trial

Huntington's disease: Latrepirdine appears well-tolerated and beneficial

Neuroscience - Third Edition eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Neurology News and Research

Latest Neurology News and Research

Neuroscience - Third Edition eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in